GK
Basic information
Region (hg38): X:30653359-30731462
Links
Phenotypes
GenCC
Source:
- inborn glycerol kinase deficiency (Definitive), mode of inheritance: AR
- inborn glycerol kinase deficiency (Strong), mode of inheritance: XL
- inborn glycerol kinase deficiency (Definitive), mode of inheritance: XL
- inborn glycerol kinase deficiency (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Glycerol kinase deficiency | XL | Biochemical | Specific dietary measures (eg, fat/glycerol-restricted diet) can be beneficial | Biochemical; Neurologic | 6325658; 8651297; 9719371; 10736265; 11032329; 18607276; 21542762; 23009783 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (39 variants)
- Inborn_genetic_diseases (23 variants)
- Inborn_glycerol_kinase_deficiency (15 variants)
- GK-related_disorder (9 variants)
- not_specified (6 variants)
- History_of_neurodevelopmental_disorder (2 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GK gene is commonly pathogenic or not. These statistics are base on transcript: NM_001205019.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 25 | 4 | 4 | 33 | ||
| missense | 3 | 2 | 72 | 6 | 83 | |
| nonsense | 3 | 2 | 5 | 10 | ||
| start loss | 0 | |||||
| frameshift | 2 | 2 | 4 | |||
| splice donor/acceptor (+/-2bp) | 3 | 5 | 53 | 61 | ||
| Total | 11 | 11 | 155 | 10 | 4 |
Highest pathogenic variant AF is 0.00035546644
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| GK | protein_coding | protein_coding | ENST00000378943 | 20 | 77250 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125687 | 0 | 3 | 125690 | 0.0000119 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.19 | 81 | 211 | 0.383 | 0.0000156 | 3616 |
| Missense in Polyphen | 13 | 75.463 | 0.17227 | 1380 | ||
| Synonymous | 0.776 | 64 | 72.4 | 0.884 | 0.00000565 | 1040 |
| Loss of Function | 4.27 | 3 | 26.9 | 0.112 | 0.00000199 | 445 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000738 | 0.0000738 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000125 | 0.00000880 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Key enzyme in the regulation of glycerol uptake and metabolism.;
- Pathway
- Glycerolipid metabolism - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Familial lipoprotein lipase deficiency;Glycerolipid Metabolism;Glycerol Kinase Deficiency;D-glyceric acidura;Fatty Acid Beta Oxidation;Type II diabetes mellitus;Triacylglyceride Synthesis;Metabolism of lipids;Metabolism;CDP-diacylglycerol biosynthesis;Glycerophospholipid metabolism;Triglyceride biosynthesis;Triglyceride metabolism;glycerol degradation
(Consensus)
Recessive Scores
- pRec
- 0.444
Intolerance Scores
- loftool
- 0.121
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 33.97
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.151
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Low | Low |
| Primary Immunodeficiency | Medium | Low | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- glycerol metabolic process;triglyceride metabolic process;phosphorylation;triglyceride biosynthetic process;glycerol catabolic process;glycerol-3-phosphate biosynthetic process
- Cellular component
- cytoplasm;mitochondrion;mitochondrial outer membrane;cytosol;extracellular exosome
- Molecular function
- glycerol kinase activity;protein binding;ATP binding